January 5, 2024 Comments Off on New patent for Boehringer Ingelheim drug SYNJARDY Posted in: Patent Added Annual Drug Patent Expirations for SYNJARDY Synjardy is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are eight patents…
The post New patent for Boehringer Ingelheim drug SYNJARDY appeared…
January 5, 2024 Comments Off on New patent for Boehringer Ingelheim drug JARDIANCE Posted in: Patent Added Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are eight patents…
The post New patent for Boehringer Ingelheim drug JARDIANCE appe…